713 related articles for article (PubMed ID: 27657493)
1. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
[TBL] [Abstract][Full Text] [Related]
2. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
3. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
[TBL] [Abstract][Full Text] [Related]
5. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.
Demirtas CO; Gunduz F; Tuney D; Baltacioglu F; Kani HT; Bugdayci O; Alahdab YO; Ozdogan OC
Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):517-523. PubMed ID: 31524775
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
[TBL] [Abstract][Full Text] [Related]
10. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
[TBL] [Abstract][Full Text] [Related]
11. Non-contrast short MRI surveillance for HCC screening: the study protocol of the SMS-HCC prospective multicenter study.
van de Braak C; Willemssen FEJA; de Man RA; van der Lugt A; Uyl-de Groot CA; Bos D; Dwarkasing RS
Eur Radiol Exp; 2024 Mar; 8(1):29. PubMed ID: 38467990
[TBL] [Abstract][Full Text] [Related]
12. Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
J Gastroenterol Hepatol; 2020 Oct; 35(10):1795-1803. PubMed ID: 32222111
[TBL] [Abstract][Full Text] [Related]
13. Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules.
Franzè MS; Bottari A; Caloggero S; Pitrone A; Barbera A; Lembo T; Caccamo G; Cacciola I; Maimone S; Alibrandi A; Pitrone C; Squadrito G; Raimondo G; Saitta C
Intern Emerg Med; 2021 Jun; 16(4):949-955. PubMed ID: 33111165
[TBL] [Abstract][Full Text] [Related]
14. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
[TBL] [Abstract][Full Text] [Related]
15. Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance.
An JY; Peña MA; Cunha GM; Booker MT; Taouli B; Yokoo T; Sirlin CB; Fowler KJ
Radiographics; 2020; 40(7):1916-1931. PubMed ID: 33136476
[TBL] [Abstract][Full Text] [Related]
16. Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score.
Truong TN; Pham TND; Hoang LB; Nguyen VT; Dao HV; Dao DVB; Alessy S; Pham HB; Pham TTT; Nguyen LDD; Nguyen K; Abaalkhail F; Manal M; Mawardi M; AlZahrani M; Alswat K; Alghamdi H; Sanai FM; Siddiqui MA; Nguyen NH; Vaidya D; Phan HT; Johnson PJ; Alqahtani SA; Dao DY
BMC Cancer; 2023 Sep; 23(1):875. PubMed ID: 37723439
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
[TBL] [Abstract][Full Text] [Related]
18. Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs.
Paisant A; Vilgrain V; Riou J; Oberti F; Sutter O; Laurent V; Rodes A; Guiu B; Cassinotto C; Trillaud H; Bricault I; Michalak S; Bruno O; Ronot M; Aubé C
J Hepatol; 2020 May; 72(5):937-945. PubMed ID: 31870951
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
20. Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.
Kim DH; Yoon JH; Choi MH; Lee CH; Kang TW; Kim HA; Ku YM; Lee JM; Kim SH; Kim KA; Lee SL; Choi JI
J Hepatol; 2024 Apr; ():. PubMed ID: 38636849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
